Article Categories

»	Arts & Entertainment
»	Automotive
»	Business
»	Careers & Jobs
»	Education & Reference
»	Finance
»	Food & Drink
»	Health & Fitness
»	Home & Family
»	Internet & Online Businesses
»	Miscellaneous
»	Self Improvement
»	Shopping
»	Society & News
»	Sports & Recreation
»	Technology
»	Travel & Leisure
»	Writing & Speaking

Reprint Article Code

Category: Articles » Business » Press Releases » Article » Article Code

Suboxone for the Opiate User

Suboxone, Was introduced to the public only a short time ago I don't have the exact date but while it has been on the market it has mad tremendous impact on the opiate dependant population. It has been reported that there is an estimated 1.1 million intravenous opiate user's world wide. And since this new drug has been introduced that population has been dramatically decreasing in size. Suboxone ( an alternative to Methadone) was created for the user to be able to avoid withdrawal symptoms while in the mean time during treatment rebuilding the receptors in the brain that ... read more

Article Title:

Article Body:

Suboxone ( an alternative to Methadone) was created for the user to be able to avoid withdrawal symptoms while in the mean time during treatment rebuilding the receptors in the brain that have been destroyed while using narcotics.

Suboxone® comes in tablets of 2 mg and 8 mg, but virtually no one will respond to the 2 mg dose. In general, 8 mg or 16 mg is the optimal dose.

On December 8, 2006, Federal legislation was passed allowing physicians to treat up to 100 opioid dependent patients with Suboxone at any given time—a significant increase from the previous limit of 30 patients.

Currently is the only centrally-approved product for treatment of opioid dependence in the European Union (EU). The approval results in Marketing Authorization with unified labeling that is valid in the current 25 EU member states as well as in Iceland and Norway. The approval follows a positive opinion recommending approval that was granted on July 27 by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA).

''This medication has the potential to wipe out at least 50 percent of the national demand for heroin," said Dr. Claude Curran , a Fall River psychiatrist who defied the federal limit last year. Curran prescribed Suboxone to 800 patients before the DEA forced him to dramatically scale back by transferring patients to other doctors or terminating their treatment.

Author Bio:

Some other recently published press releases articles

Oceanfront & Golf Course-front Luxury House Now for Sale by Ester Rebecca del Fierro
Hawthorn, Australia - 20th day of February, 2007 --This is a rare opportunity to acquire prime real estate close to a ...

What You Should Know About Cleaning Your Registry by adam archer
Using a Window Registry Cleaner The most important and critical element to any operating system from Microsoft is its registry, and you require ...

Stop Searching, Training Your Dog Can Be Fun by adam archer
It doesn't matter what type of dog training help your looking for, For instance it might be,petsmart dog training, boyton dog train, train dog to stop barking, training older dogs, train loud barking dogs, dog ...

Suboxone for the Opiate User by adam archer
Suboxone, Was introduced to the public only a short time ago I don't have the exact date but while it has ...

Resume writing of ProfEssays by Andrew Sandon
Custom essay writing service ProfEssays offers a new service of resume writing. At the same time this custom essay writing company ...

ProfEssays is making headway by Roger Green
In order to provide our customers with original and excellent custom essays, custom writing company ProfEssays recruit only professional and talented researchers and writers. All of our ...

Publisher Guidelines

You may reprint this article electronically in your newsletter or on your website, free of charge.

If you reprint this article from our site, then you must keep everything intact. This includes the articles title, author name, articles body, authors bio / resource box, the links contained within the article, all copyright notices and the link pointing back to our site. All links within the article must also be made active / hyperlinks.